India Takes New Stab at Reforming Clinical Trial Compensation Rules

International Pharmaceutical Regulatory Monitor
A A
Drugmakers could be hit with huge medical bills for patients harmed during clinical trials, if proposed reforms to India’s drug laws are adopted.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00